Nasal Nitric Oxide Levels in EoE


About this study

This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • Subjects with dysphagia and active esophageal infiltration (esophageal eosinophilic count of ≥15 eos/hpf)
  • Subjects with or without a clinical diagnosis of asthma

Exclusion criteria:

  • Tuberculosis
  • The inablity to read due to blindness, cognitive dysfunction or English language illiteracy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Vivek Iyer, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer